148 related articles for article (PubMed ID: 8313111)
21. Flow cytometric measurement of proliferation-associated nuclear antigen P105 and DNA content in immuno-proliferative small intestinal disease (IPSID).
Demirer T; Uzunalimoglu O; Anderson T; Koethe SM; McFadden PW; Demirer S; Uzunalimoglu B; Kucuk O
J Surg Oncol; 1995 Jan; 58(1):25-30. PubMed ID: 7529850
[TBL] [Abstract][Full Text] [Related]
22. Roles of syndecan-1, bcl6 and p53 in diagnosis and prognostication of immunoproliferative small intestinal disease.
Vaiphei K; Kumari N; Sinha SK; Dutta U; Nagi B; Joshi K; Singh K
World J Gastroenterol; 2006 Jun; 12(22):3602-8. PubMed ID: 16773719
[TBL] [Abstract][Full Text] [Related]
23. Immunoproliferative small intestinal disease without alpha-chain disease: a pathological study.
Cammoun M; Jaafoura H; Tabbane F; Halphen M
Gastroenterology; 1989 Mar; 96(3):750-63. PubMed ID: 2914638
[TBL] [Abstract][Full Text] [Related]
24. Immunoproliferative small intestinal disease (IPSID) in Thailand.
Pramoolsinsap C; Kurathong S; Atichartakarn V; Nitiyanand P
Southeast Asian J Trop Med Public Health; 1993 Mar; 24(1):11-7. PubMed ID: 8362283
[TBL] [Abstract][Full Text] [Related]
25. IgA plasmablastic large B-cell lymphoma.
Roncati L; Maiorana A
Diagnosis (Berl); 2017 Jun; 4(2):105-107. PubMed ID: 29536914
[No Abstract] [Full Text] [Related]
26. The Evolution of Our Understanding of Immunoproliferative Small Intestinal Disease (IPSID) over Time.
AlYamany R; Kharfan-Dabaja MA; Hamadani M; Alshaibani A; Aljurf M
Curr Oncol; 2022 May; 29(5):3759-3769. PubMed ID: 35621691
[TBL] [Abstract][Full Text] [Related]
27. [Libyan patient with chronic diarrhea].
Mezger J; Malfertheiner P; Glasmacher A; Breuer TH; Fischer HP; Meybehm M; Kipnowski HJ; Sauerbruch T
Z Gastroenterol; 1996 Oct; 34(10):699-703. PubMed ID: 9012223
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological features and management of immunoproliferative small intestinal disease and primary small intestinal lymphoma in Pakistan.
Malik IA; Shamsi Z; Shafquat A; Aziz Z; Shaikh H; Jafri W; Khan MA; Khan AH
Med Pediatr Oncol; 1995 Nov; 25(5):400-6. PubMed ID: 7674998
[TBL] [Abstract][Full Text] [Related]
29. Immunoproliferative small intestinal disease in Greece: presentation of 13 cases including two from Albania.
Economidou I; Manousos ON; Triantafillidis JK; Vaslamatzis MM; Zafiropoulou R; Papadakis T
Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):1029-38. PubMed ID: 16894320
[TBL] [Abstract][Full Text] [Related]
30. Immunoproliferative small intestinal disease: portrait of a potentially preventable cancer from the Third World.
Khojasteh A; Haghighi P
Am J Med; 1990 Oct; 89(4):483-90. PubMed ID: 2145762
[TBL] [Abstract][Full Text] [Related]
31. Campylobacter coli cultured from the stools of a patient with immunoproliferative small intestinal disease.
Coeuret S; de La Blanchardière A; Saguet-Rysanek V; Chèze S; Tavernier M; Arsène D; Criscuolo A; Brisse S; Vergnaud M; Verdon R; Lecuit M
Clin Microbiol Infect; 2014 Sep; 20(9):908-11. PubMed ID: 24438451
[TBL] [Abstract][Full Text] [Related]
32. Immunoproliferative small intestinal disease: a frequently missed diagnosis.
Puri AS; Kumar M; Khan EM; Pandey R; Aggarwal R; Naik S; Choudhuri G; Naik SR
Indian J Gastroenterol; 1996 Apr; 15(2):46-8. PubMed ID: 8935933
[TBL] [Abstract][Full Text] [Related]
33. Malabsorption associated with nonmalignant immunoproliferative small intestinal disease.
Manousos O; Economidou J; Papademetriou C; Triantaphyllidis J; Constandinidou N; Stathopoulos A
Digestion; 1987; 36(3):182-8. PubMed ID: 3596077
[TBL] [Abstract][Full Text] [Related]
34. Treating chronic diarrhea: A systematic review on Immunoproliferative Small Intestinal Disease (IPSID).
Evangelista-Leite D; Affonso Madaloso B; Shouta Yamashita B; Enrico Aloise F; Polito Verdasca L; Lopes de Mello M; Murata Hayashi R; Zimberg Chehter E
PLoS One; 2021; 16(7):e0253695. PubMed ID: 34270561
[TBL] [Abstract][Full Text] [Related]
35. Gastrointestinal lymphoma.
Thomas CR; Share R
Med Pediatr Oncol; 1991; 19(1):48-60. PubMed ID: 1990257
[TBL] [Abstract][Full Text] [Related]
36. Immunoproliferative small-intestinal disease: follow-up of an alpha-chain negative, lymphoma-free group.
Gilinsky NH; Novis BH; Mee AS; Wright JP; Price S; Marks IN
J Clin Gastroenterol; 1983 Oct; 5(5):421-8. PubMed ID: 6415158
[TBL] [Abstract][Full Text] [Related]
37. Immunoproliferative small intestinal disease with duodenojejunal lymphoma: radiologic changes.
Vessal K; Dutz W; Kohout E; Rezvani L
AJR Am J Roentgenol; 1980 Sep; 135(3):491-7. PubMed ID: 6773368
[TBL] [Abstract][Full Text] [Related]
38. Immunoproliferative Small Intestinal Disease Associated with Overwhelming Polymicrobial Gastrointestinal Infection with Transformation to Diffuse Large B-cell Lymphoma.
Ewers EC; Sheffler RL; Wang J; Ngauy V
Am J Trop Med Hyg; 2016 May; 94(5):1177-81. PubMed ID: 26903604
[TBL] [Abstract][Full Text] [Related]
39. Immunoproliferative small-intestinal disease. An immunohistochemical study.
Isaacson PG; Dogan A; Price SK; Spencer J
Am J Surg Pathol; 1989 Dec; 13(12):1023-33. PubMed ID: 2512818
[TBL] [Abstract][Full Text] [Related]
40. Immunoproliferative small intestinal disease in Mexico. Report of four cases and review of the literature.
Arista-Nasr J; González-Romo MA; Mantilla-Morales A; Lazos-Ochoa M; Ortiz-Hidalgo C
J Clin Gastroenterol; 1994 Jan; 18(1):67-71. PubMed ID: 8113590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
